MRSN logo

Mersana Therapeutics (MRSN) Net Income

Annual Net Income

-$69.19 M
+$102.48 M+59.69%

December 31, 2024

Summary

Performance

1-Year Change

+59.69%

3-Year Change

+59.31%

5-Year Change

-145.29%

15-Year Change

-78.76%

MRSN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.64%
MRSN annual net profit is higher than 28.64% of companies in Healthcare sector

High & Low

All-time High

-$13.70 M

3-Year Low

-$204.21 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MRSN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
MRSN next annual earnings announcement has not yet been scheduled

OtherMRSNprofitabilitymetrics:

Annual Net Margin

-170.86%
MRSN annual net profit margin is -170.86%

Annual Revenue

$40.50 M
MRSN annual revenue is $40.50 million

Annual Gross Profit

-
MRSN annual gross profit value is unknown

Annual EPS

-$0.56
MRSN annual earnings per share is -$0.56

Quarterly Net Income

-$14.12 M
-$2.62 M-22.75%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

MRSN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.59%
MRSN quarterly net profit is higher than 33.59% of companies in Healthcare sector

High & Low

All-time High

$21.90 M
MRSN quarterly net profit is currently -164.46% below its historical high of $21.90 million

3-Year Low

-$59.81 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
MRSN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
MRSN next earnings announcement is scheduled for May 9, 2025

OtherMRSNprofitabilitymetrics:

Quarterly Net Margin

-86.28%
MRSN quarterly net profit margin is -86.28%

Quarterly Revenue

$16.36 M
MRSN quarterly revenue is $16.36 million

Quarterly Gross Profit

-
MRSN quarterly gross profit value is unknown

Quarterly EPS

-$0.11
MRSN quarterly earnings per share is -$0.11

TTM Net Income

-$69.19 M
+$5.43 M+7.27%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

MRSN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.41%
MRSN TTM net profit is higher than 29.41% of companies in Healthcare sector

High & Low

All-time High

-$5.36 M

3-Year Low

-$215.21 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
MRSN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
MRSN next earnings announcement is scheduled for May 9, 2025

OtherMRSNprofitabilitymetrics:

Annual Net Margin

-170.86%
MRSN annual net profit margin is -170.86%

TTM Revenue

$40.50 M
MRSN TTM revenue is $40.50 million

TTM Gross Profit

-
MRSN TTM gross profit value is unknown

TTM EPS

-$0.56
MRSN TTM earnings per share is -$0.56

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$69.19 M
MRSN annual net profit is -$69.19 million

Annual Revenue

$40.50 M
MRSN annual revenue is $40.50 million

Annual Cost Of Goods Sold

-
MRSN annual cost of goods sold value is unknown

Annual Operating Expenses

$113.83 M
MRSN annual total operating expenses is $113.83 million

Annual Interest Expense

$3.87 M
MRSN annual interest expense is $3.87 million

Annual Income Tax

$418.00 K
MRSN annual income tax is $418.00 thousand

MRSN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+59.7%0.0%0.0%
3 y3 years+59.3%0.0%0.0%
5 y5 years-145.3%0.0%0.0%

MRSN Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+66.1%-22.8%+76.4%at high+67.8%
5 y5-year-145.3%+66.1%-22.8%+76.4%-145.3%+67.8%
alltimeall time-405.1%+66.1%-164.5%+76.4%-1191.9%+67.8%

Mersana Therapeutics Net Income History

DateAnnualQuarterlyTTM
Dec 2024
-$69.19 M(-59.7%)
-$14.12 M(+22.7%)
-$69.19 M(-7.3%)
Sep 2024
-
-$11.50 M(-52.6%)
-$74.62 M(-28.8%)
Jun 2024
-
-$24.27 M(+25.7%)
-$104.77 M(-22.3%)
Mar 2024
-
-$19.31 M(-1.2%)
-$134.81 M(-21.5%)
Dec 2023
-$171.67 M(-15.9%)
-$19.54 M(-53.1%)
-$171.67 M(-12.9%)
Sep 2023
-
-$41.66 M(-23.3%)
-$197.05 M(-8.4%)
Jun 2023
-
-$54.31 M(-3.3%)
-$215.21 M(+1.0%)
Mar 2023
-
-$56.16 M(+25.0%)
-$213.12 M(+4.4%)
Dec 2022
-$204.21 M(+20.1%)
-$44.92 M(-24.9%)
-$204.21 M(-1.9%)
Sep 2022
-
-$59.81 M(+14.5%)
-$208.27 M(+7.4%)
Jun 2022
-
-$52.22 M(+10.5%)
-$193.93 M(+6.2%)
Mar 2022
-
-$47.26 M(-3.5%)
-$182.63 M(+7.4%)
Dec 2021
-$170.06 M(+93.2%)
-$48.98 M(+7.7%)
-$170.06 M(+13.4%)
Sep 2021
-
-$45.47 M(+11.1%)
-$149.92 M(+18.1%)
Jun 2021
-
-$40.91 M(+17.9%)
-$126.94 M(+20.0%)
Mar 2021
-
-$34.69 M(+20.3%)
-$105.81 M(+20.2%)
Dec 2020
-$88.05 M
-$28.84 M(+28.2%)
-$88.04 M(+16.7%)
Sep 2020
-
-$22.49 M(+13.7%)
-$75.45 M(+8.2%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$19.79 M(+16.9%)
-$69.75 M(+4.1%)
Mar 2020
-
-$16.93 M(+4.2%)
-$67.03 M(+137.6%)
Dec 2019
-$28.21 M(-56.1%)
-$16.25 M(-3.3%)
-$28.21 M(-18.0%)
Sep 2019
-
-$16.79 M(-1.6%)
-$34.39 M(-0.8%)
Jun 2019
-
-$17.07 M(-177.9%)
-$34.67 M(+15.7%)
Mar 2019
-
$21.90 M(-197.6%)
-$29.95 M(-53.4%)
Dec 2018
-$64.26 M(+66.0%)
-$22.43 M(+31.4%)
-$64.26 M(+15.2%)
Sep 2018
-
-$17.07 M(+38.2%)
-$55.79 M(+20.1%)
Jun 2018
-
-$12.35 M(-0.4%)
-$46.46 M(+7.9%)
Mar 2018
-
-$12.40 M(-11.2%)
-$43.05 M(+11.2%)
Dec 2017
-$38.71 M(+182.5%)
-$13.97 M(+80.6%)
-$38.71 M(+64.8%)
Sep 2017
-
-$7.73 M(-13.6%)
-$23.48 M(+8.8%)
Jun 2017
-
-$8.95 M(+11.0%)
-$21.59 M(+31.6%)
Mar 2017
-
-$8.06 M(-740.3%)
-$16.41 M(+19.7%)
Dec 2016
-$13.70 M(-16.6%)
$1.26 M(-121.6%)
-$13.70 M(-8.4%)
Sep 2016
-
-$5.84 M(+55.0%)
-$14.96 M(+64.0%)
Jun 2016
-
-$3.77 M(-29.7%)
-$9.12 M(+70.3%)
Mar 2016
-
-$5.36 M
-$5.36 M
Dec 2015
-$16.43 M
-
-

FAQ

  • What is Mersana Therapeutics annual net profit?
  • What is the all time high annual net income for Mersana Therapeutics?
  • What is Mersana Therapeutics annual net income year-on-year change?
  • What is Mersana Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Mersana Therapeutics?
  • What is Mersana Therapeutics quarterly net income year-on-year change?
  • What is Mersana Therapeutics TTM net profit?
  • What is the all time high TTM net income for Mersana Therapeutics?
  • What is Mersana Therapeutics TTM net income year-on-year change?

What is Mersana Therapeutics annual net profit?

The current annual net income of MRSN is -$69.19 M

What is the all time high annual net income for Mersana Therapeutics?

Mersana Therapeutics all-time high annual net profit is -$13.70 M

What is Mersana Therapeutics annual net income year-on-year change?

Over the past year, MRSN annual net profit has changed by +$102.48 M (+59.69%)

What is Mersana Therapeutics quarterly net profit?

The current quarterly net income of MRSN is -$14.12 M

What is the all time high quarterly net income for Mersana Therapeutics?

Mersana Therapeutics all-time high quarterly net profit is $21.90 M

What is Mersana Therapeutics quarterly net income year-on-year change?

Over the past year, MRSN quarterly net profit has changed by $0.00 (0.00%)

What is Mersana Therapeutics TTM net profit?

The current TTM net income of MRSN is -$69.19 M

What is the all time high TTM net income for Mersana Therapeutics?

Mersana Therapeutics all-time high TTM net profit is -$5.36 M

What is Mersana Therapeutics TTM net income year-on-year change?

Over the past year, MRSN TTM net profit has changed by $0.00 (0.00%)